Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.
Press releases published on April 3, 2025
Zefiro Founder and CEO Appears on Orphan and Marginal Wells Panel in Fort Worth, Texas Led by JPMorganChase Head of Operational Decarbonization
GlobeNewswire
·
April 3, 2025
The annual event, which is hosted by the Neeley School of Business and was sponsored by JPMorgan and Double Eagle Energy Holdings, provides a forum for leaders across the energy industry to address pressing production and sustainability-related issues FORT …
ICON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against ICON plc - ICLR
GlobeNewswire
·
April 3, 2025
NEW ORLEANS, April 03, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 11, 2025 to file lead plaintiff applications in securities class action lawsuits against ICON plc (the “ …
THE BANCORP SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Bancorp, Inc. - TBBK
GlobeNewswire
·
April 3, 2025
NEW ORLEANS, April 03, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against The Bancorp, Inc. (“ …
READY CAPITAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ready Capital Corporation - RC
GlobeNewswire
·
April 3, 2025
NEW ORLEANS, April 03, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5, 2025 to file lead plaintiff applications in a securities class action lawsuit against Ready Capital …
Vaxil: Management and Operational Update
GlobeNewswire
·
April 3, 2025
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the Company’s activities, …
FioBit Ranks Among Top Trending Australian Investment Banks on Crunchbase — Crypto Mining Industry News
GlobeNewswire
·
April 3, 2025
Macquarie Park, Sydney, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Recently, global business intelligence platform Crunchbase published its latest trending organizations in the Australian investment banking sector, revealing a surprising and noteworthy …
ExoraPad Raises Over 60,000 XRP In Token Presale, Could This Be Ripple's Next 100X Gem?
GlobeNewswire
·
April 3, 2025
CORK, Ireland, April 03, 2025 (GLOBE NEWSWIRE) -- ExoraPad ($EXP), an innovative AI-powered launchpad exclusively developed for the XRP Ledger (XRPL), has reached an impressive milestone by raising over 60,000 XRP in its ongoing presale. Investors are …
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025
GlobeNewswire
·
April 3, 2025
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 OSE-CYTOMASK®, a new CIS-Demasking1 cytokine bispecific technology. CLEC-1, a novel immune checkpoint target. NANTES, France – April 3, 2025, 6:00 p.m. CET - …
ExaGrid Awarded 2025 “Data Backup Solution of the Year” By Data Breakthrough
GlobeNewswire
·
April 3, 2025
LOS ANGELES, April 03, 2025 (GLOBE NEWSWIRE) -- Data Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global data technology market, today announced that ExaGrid®, the …
Actian Recognized for Metadata Management Innovation in 2025 Data Breakthrough Awards Program
GlobeNewswire
·
April 3, 2025
LOS ANGELES, April 03, 2025 (GLOBE NEWSWIRE) -- Data Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global data technology market, today announced that Actian, the data …
Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025
GlobeNewswire
·
April 3, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 3 APRIL 2025 at 16.20 EEST Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025 At the Annual General Meeting of Orion Corporation held today, the …
Orion Oyj:n varsinaisen yhtiökokouksen päätökset 3.4.2025
GlobeNewswire
·
April 3, 2025
ORION OYJ PÖRSSITIEDOTE – YHTIÖKOKOUKSEN PÄÄTÖKSET 3.4.2025 KLO 16.20 Orion Oyj:n varsinaisen yhtiökokouksen päätökset 3.4.2025 Orion Oyj:n tänään pidetty varsinainen yhtiökokous: Vahvisti maksettavaksi osingoksi 1,64 …
Nutanix Announces 2025 .NEXT Event Lineup: Shape the Next Era of AI, Cloud Native, and Hybrid Multicloud Innovation
GlobeNewswire
·
April 3, 2025
SAN JOSE, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced the programming for its .NEXT 2025 event, set to take place in Washington, D.C., from May 7-9, 2025. As artificial …
Senti Bio to Showcase SENTI-202 Clinical Data and Novel Logic Gated Gene Circuit Mechanism of Action in Oral and Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 3, 2025
SOUTH SAN FRANCISCO, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Drone Surveying Industry Witnessing Continuous Technological Advancements Generating Rising Revenue Opportunity
GlobeNewswire
·
April 3, 2025
PALM BEACH, Fla., April 03, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The drone surveying market is witnessing increased demand for its services across different industries. The survey done by drones has multiple benefits in comparison to …
Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
FLORHAM PARK, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of …
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
GlobeNewswire
·
April 3, 2025
MOUNTAIN VIEW, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, will be attending and presenting at the upcoming American Academy of …
Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN
GlobeNewswire
·
April 3, 2025
On track to announce primary endpoint result from ORIGIN 3 trial this quarter (2Q 2025) U.S. FDA BLA submission for accelerated approval planned for 2H 2025 BRISBANE, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late …
ZenaTech Closes Second Southeast Region Acquisition, Wallace Surveying Corporation, Set to Become the Third Acquisition to Power Its National Drone as a Service (DaaS) Business
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone-as-a-Service (DaaS), enterprise SaaS and …
Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome
GlobeNewswire
·
April 3, 2025
MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria Rare Pediatric Designation granted MNV-201 is also being studied in a Phase Ib for low-risk …